Anticoagulation therapy. Dabigatran and risk of myocardial infarction.

Autor: Eikelboom JW; Thrombosis and Atherosclerosis Research Institute, McMaster University, 237 Barton Street East, Hamilton, Ontario, Canada., Weitz JI
Jazyk: angličtina
Zdroj: Nature reviews. Cardiology [Nat Rev Cardiol] 2012 Mar 13; Vol. 9 (5), pp. 260-2. Date of Electronic Publication: 2012 Mar 13.
DOI: 10.1038/nrcardio.2012.34
Abstrakt: Dabigatran has been associated with an increase in acute coronary events when compared with warfarin in several randomized trials, and now in a meta-analysis by Uchino and Hernandez. We critically review the evidence for this association and consider the implications for patient care.
Databáze: MEDLINE